2026
Airway Medix Successfully Completes First Surveillance Audit, Maintains ISO 13485 Certification
Airway Medix passed its first ISO 13485 surveillance audit without any nonconformities and keeps the certificate issued by CeCert. The certified system covers design, manufacturing and sales of the company's medical devices and supports its activities in the EU, the US and other markets.
Airway Medix Announces Leadership Transition as Anna Aranowska-Bablok Steps Down as CEO
Anna Aranowska-Bablok steps down as CEO with effect from 31 August 2026 after twelve years with the company. During her tenure Airway Medix raised more than EUR 3 million, moved research, development and production to Europe and launched its first product in early 2026.
Airway Medix S.A. Appoints New Supervisory Board Member and Nominates Two Candidates for Upcoming Extraordinary General Assembly
Dr. Matthias Kuss joins the Supervisory Board of Airway Medix S.A. Christophe Geisert and Julius Brandt are nominated for election at the upcoming Extraordinary General Assembly.
Airway Medix S.A. Confirms Execution of Its Strategic Direction
Airway Medix confirms the shift from a research and development company to an international trading company with its own products. The release describes the governance changes and the partnerships in Germany and Europe that support this direction.
